51
|
Gallardo ME, Desviat LR, Rodríguez JM, Esparza-Gordillo J, Pérez-Cerdá C, Pérez B, Rodríguez-Pombo P, Criado O, Sanz R, Morton DH, Gibson KM, Le TP, Ribes A, de Córdoba SR, Ugarte M, Peñalva MÁ. The molecular basis of 3-methylcrotonylglycinuria, a disorder of leucine catabolism. Am J Hum Genet 2001; 68:334-46. [PMID: 11170888 PMCID: PMC1235267 DOI: 10.1086/318202] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2000] [Accepted: 12/12/2000] [Indexed: 11/03/2022] Open
Abstract
3-Methylcrotonylglycinuria is an inborn error of leucine catabolism and has a recessive pattern of inheritance that results from the deficiency of 3-methylcrotonyl-CoA carboxylase (MCC). The introduction of tandem mass spectrometry in newborn screening has revealed an unexpectedly high incidence of this disorder, which, in certain areas, appears to be the most frequent organic aciduria. MCC, an heteromeric enzyme consisting of alpha (biotin-containing) and beta subunits, is the only one of the four biotin-dependent carboxylases known in humans that has genes that have not yet been characterized, precluding molecular studies of this disease. Here we report the characterization, at the genomic level and at the cDNA level, of both the MCCA gene and the MCCB gene, encoding the MCC alpha and MCC beta subunits, respectively. The 19-exon MCCA gene maps to 3q25-27 and encodes a 725-residue protein with a biotin attachment site; the 17-exon MCCB gene maps to 5q12-q13 and encodes a 563-residue polypeptide. We show that disease-causing mutations can be classified into two complementation groups, denoted "CGA" and "CGB." We detected two MCCA missense mutations in CGA patients, one of which leads to absence of biotinylated MCC alpha. Two MCCB missense mutations and one splicing defect mutation leading to early MCC beta truncation were found in CGB patients. A fourth MCCB mutation also leading to early MCC beta truncation was found in two nonclassified patients. A fungal model carrying an mccA null allele has been constructed and was used to demonstrate, in vivo, the involvement of MCC in leucine catabolism. These results establish that 3-methylcrotonylglycinuria results from loss-of-function mutations in the genes encoding the alpha and beta subunits of MCC and complete the genetic characterization of the four human biotin-dependent carboxylases.
Collapse
MESH Headings
- Adult
- Amino Acid Metabolism, Inborn Errors/enzymology
- Amino Acid Metabolism, Inborn Errors/genetics
- Amino Acid Metabolism, Inborn Errors/pathology
- Amino Acid Sequence
- Aspergillus nidulans/drug effects
- Aspergillus nidulans/genetics
- Aspergillus nidulans/growth & development
- Base Sequence
- Blotting, Northern
- Carbon-Carbon Ligases/genetics
- Carbon-Carbon Ligases/metabolism
- Child, Preschool
- Chromosome Mapping
- Chromosomes, Human, Pair 3/genetics
- Chromosomes, Human, Pair 5/genetics
- DNA/chemistry
- DNA/genetics
- DNA Mutational Analysis
- DNA, Complementary/chemistry
- DNA, Complementary/genetics
- Exons
- Female
- Gene Expression Regulation, Enzymologic
- Genes/genetics
- Humans
- In Situ Hybridization, Fluorescence
- Infant
- Introns
- Isoenzymes/genetics
- Isoenzymes/metabolism
- Leucine/metabolism
- Leucine/pharmacology
- Molecular Sequence Data
- Mutation
- Protein Subunits
- RNA/genetics
- RNA/metabolism
- Radiation Hybrid Mapping
- Sequence Analysis, DNA
- Tissue Distribution
- Transcription, Genetic
Collapse
Affiliation(s)
- M. Esther Gallardo
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - Lourdes R. Desviat
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - José M. Rodríguez
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - Jorge Esparza-Gordillo
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - Celia Pérez-Cerdá
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - Belén Pérez
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - Pilar Rodríguez-Pombo
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - Olga Criado
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - Raul Sanz
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - D. Holmes Morton
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - K. Michael Gibson
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - Thuy P. Le
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - Antonia Ribes
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - Santiago Rodríguez de Córdoba
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - Magdalena Ugarte
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| | - Miguel Á. Peñalva
- Centro de Investigaciones Biológicas CSIC, Fundación Jiménez Díaz, and Centro de Biología Molecular CSIC-UAM, Universidad Autónoma de Madrid, Madrid; Clinic for Special Children, Strasburg, PA; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla; and Institut de Bioquímica Clìnica, Corporació Sanitària Clínic, Barcelona
| |
Collapse
|
52
|
Johnston JJ, Kelley RI, Crawford TO, Morton DH, Agarwala R, Koch T, Schäffer AA, Francomano CA, Biesecker LG. A novel nemaline myopathy in the Amish caused by a mutation in troponin T1. Am J Hum Genet 2000; 67:814-21. [PMID: 10952871 PMCID: PMC1287886 DOI: 10.1086/303089] [Citation(s) in RCA: 227] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2000] [Accepted: 08/02/2000] [Indexed: 11/03/2022] Open
Abstract
The nemaline myopathies are characterized by weakness and eosinophilic, rodlike (nemaline) inclusions in muscle fibers. Amish nemaline myopathy is a form of nemaline myopathy common among the Old Order Amish. In the first months of life, affected infants have tremors with hypotonia and mild contractures of the shoulders and hips. Progressive worsening of the proximal contractures, weakness, and a pectus carinatum deformity develop before the children die of respiratory insufficiency, usually in the second year. The disorder has an incidence of approximately 1 in 500 among the Amish, and it is inherited in an autosomal recessive pattern. Using a genealogy database, automated pedigree software, and linkage analysis of DNA samples from four sibships, we identified an approximately 2-cM interval on chromosome 19q13.4 that was homozygous in all affected individuals. The gene for the sarcomeric thin-filament protein, slow skeletal muscle troponin T (TNNT1), maps to this interval and was sequenced. We identified a stop codon in exon 11, predicted to truncate the protein at amino acid 179, which segregates with the disease. We conclude that Amish nemaline myopathy is a distinct, heritable, myopathic disorder caused by a mutation in TNNT1.
Collapse
Affiliation(s)
- J J Johnston
- Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
53
|
Morton DH, Salen G, Batta AK, Shefer S, Tint GS, Belchis D, Shneider B, Puffenberger E, Bull L, Knisely AS. Abnormal hepatic sinusoidal bile acid transport in an Amish kindred is not linked to FIC1 and is improved by ursodiol. Gastroenterology 2000; 119:188-95. [PMID: 10889168 DOI: 10.1053/gast.2000.8547] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/02/2022]
Abstract
BACKGROUND & AIMS The mechanism for abnormal hepatic bile acid transport was investigated in an 18-month-old Amish boy who presented with pruritus, poor growth, and severe bleeding episodes. Serum bilirubin, gamma-glutamyltranspeptidase, and cholesterol levels were normal, but prothrombin time and partial thromboplastin time were prolonged and bone alkaline phosphatase level was elevated. METHODS AND RESULTS Cholic acid plus chenodeoxycholic acid levels measured by capillary gas-chromatography were 32 times higher than control in serum (34.7 vs. 1.1+/-0.4 microg/dL) but were not detected in liver and were reduced in gallbladder bile. Treatment with ursodiol, a more hydrophilic bile acid, improved pruritus, produced 37% weight gain, and after 2 years reduced serum primary bile acid concentrations about 85%, while accounting for 71% of serum and 24% of biliary bile acid conjugates. On ursodiol therapy, hepatic bile acid synthesis was enhanced 2-fold compared with controls, and microscopy revealed chronic hepatitis without cholestasis. Three younger sisters with elevated serum bile acids responded positively to ursodiol. Microsatellite markers for the FIC1 (gene for Byler's disease) region in these 4 children were inconsistent with linkage to FIC1. CONCLUSIONS Conjugated cholic acid and chenodeoxycholic acid were synthesized in the liver and secreted into bile but could not reenter the liver from portal blood and accumulated in serum. In contrast, unconjugated ursodiol entered the liver and was conjugated and secreted into bile. Thus, the enterohepatic circulation of all conjugated bile acids was interrupted at the hepatic sinusoidal basolateral membrane. Unconjugated ursodiol bypassed the hepatic uptake block to enlarge the biliary and intestinal bile acid pools. A mutation in FIC1 recognized among the Amish and linkage of the disorder to FIC1 were excluded.
Collapse
Affiliation(s)
- D H Morton
- Clinic for Special Children, Strasburg, Pennsylvania, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
54
|
Bolk S, Puffenberger EG, Hudson J, Morton DH, Chakravarti A. Elevated frequency and allelic heterogeneity of congenital nephrotic syndrome, Finnish type, in the old order Mennonites. Am J Hum Genet 1999; 65:1785-90. [PMID: 10577936 PMCID: PMC1288392 DOI: 10.1086/302687] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- Stacey Bolk
- Department
of Genetics and Center for Human Genetics, Case Western Reserve University
School of Medicine and University Hospitals of Cleveland, Cleveland;
Clinic for Special Children, Strasburg, PA; and
Research Genetics, Huntsville
| | - Erik G. Puffenberger
- Department
of Genetics and Center for Human Genetics, Case Western Reserve University
School of Medicine and University Hospitals of Cleveland, Cleveland;
Clinic for Special Children, Strasburg, PA; and
Research Genetics, Huntsville
| | - Jim Hudson
- Department
of Genetics and Center for Human Genetics, Case Western Reserve University
School of Medicine and University Hospitals of Cleveland, Cleveland;
Clinic for Special Children, Strasburg, PA; and
Research Genetics, Huntsville
| | - D. Holmes Morton
- Department
of Genetics and Center for Human Genetics, Case Western Reserve University
School of Medicine and University Hospitals of Cleveland, Cleveland;
Clinic for Special Children, Strasburg, PA; and
Research Genetics, Huntsville
| | - Aravinda Chakravarti
- Department
of Genetics and Center for Human Genetics, Case Western Reserve University
School of Medicine and University Hospitals of Cleveland, Cleveland;
Clinic for Special Children, Strasburg, PA; and
Research Genetics, Huntsville
| |
Collapse
|
55
|
Abstract
OBJECTIVE To establish a genetic linkage between highly polymorphic microsatellite loci and the disease locus responsible for an autosomal recessive neurodegenerative syndrome that causes posterior column ataxia and retinitis pigmentosa. BACKGROUND The authors reported previously a genetic syndrome that causes visual impairment, proprioceptive loss, sensory ataxia, and areflexia in affected individuals from a large, inbred family belonging to a sectarian population that has been genetically semi-isolated from mainstream society for several centuries. METHODS To find the disease locus responsible for this condition, the authors performed a genome-wide search using genetic loci spaced at 10 to 20-cM intervals spanning human chromosomes (chr) 1-22. Pairwise linkage analysis, multipoint linkage analysis, and haplotype reconstruction were used to delineate the candidate region containing the disease gene. RESULTS After testing 226 loci that covered the entire genome, the authors identified a maximum lod score of 8.94 at a recombination fraction of 0.00 for locus D1S2692. Additional analyses placed the disease gene, AXPC1, in an 8.3-cM interval flanked by markers D1S2692 and D1S414 on chr 1q31-q32. CONCLUSIONS This study suggests that a single genetic mutation can cause selective degeneration of the posterior columns of the spinal cord and retina. Finding the gene responsible for this syndrome may increase our understanding of the molecular basis of diseases that affect sensory neurons.
Collapse
Affiliation(s)
- J J Higgins
- Laboratory of Clinical Neurogenetics, Wadsworth Center, New York State Department of Health, Albany 12201-0509, USA
| | | | | |
Collapse
|
56
|
Barić I, Zschocke J, Christensen E, Duran M, Goodman SI, Leonard JV, Müller E, Morton DH, Superti-Furga A, Hoffmann GF. Diagnosis and management of glutaric aciduria type I. J Inherit Metab Dis 1998; 21:326-40. [PMID: 9700590 DOI: 10.1023/a:1005390105171] [Citation(s) in RCA: 88] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Glutaric aciduria type I (GA1) is a preventable cause of acute brain damage in early childhood, leading to a severe dystonic-dyskinetic disorder that is similar to cerebral palsy and ranges from extreme hypotonia to choreoathetosis to rigidity with spasticity. Degeneration of the putamen and caudate typically occurs between 6 and 18 months of age and is probably linked to changes in metabolic demand caused by normal maturational changes and superimposed catabolic stress. Recognition of this biochemical disorder before the brain has been injured is essential to outcome. Diagnosis depends upon the recognition of relatively non-specific physical findings such as hypotonia, irritability and macrocephaly, and on performance of urine organic acid quantification by gas chromatography--mass spectrometry or selective searches of urine or blood specimens by tandem mass spectrometry for glutarylcarnitine. The diagnosis may also be suggested by characteristic findings on neuroimaging. In selected patients diagnosis can only be reached by enzyme assay. Specific current management by the authors of this paper includes pharmacological doses of L-carnitine, as well as dietary protein restriction. Metabolic decompensation must be treated aggressively to avoid permanent brain damage. Multicentre studies are needed to establish best methods of diagnosis and optimal therapy of this disorder.
Collapse
Affiliation(s)
- I Barić
- Department of Paediatrics, Philipps University, Marburg, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
57
|
Gibson KM, Bennett MJ, Naylor EW, Morton DH. 3-Methylcrotonyl-coenzyme A carboxylase deficiency in Amish/Mennonite adults identified by detection of increased acylcarnitines in blood spots of their children. J Pediatr 1998; 132:519-23. [PMID: 9544913 DOI: 10.1016/s0022-3476(98)70032-0] [Citation(s) in RCA: 60] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Isolated 3-methylcrotonyl coenzyme A carboxylase (MCC) deficiency was documented in four adult women from the Amish/Mennonite population of Lancaster County, Pennsylvania. Metabolic and enzymatic investigations in these individuals were instituted after the detection of abnormal acylcarnitine profiles in blood spots obtained from their newborn children, in whom MCC activity was normal.
Collapse
Affiliation(s)
- K M Gibson
- Institute of Metabolic Disease, Baylor University Medical Center, Dallas, Texas, USA
| | | | | | | |
Collapse
|
58
|
Abstract
We report an autosomal recessive form of ataxia that is not allelic to Friedreich's disease in six individuals from a large kindred with family origins traced to a common founder of German-Swiss descent. The disorder begins during early childhood with a concentric contraction of the visual fields and proprioceptive loss. Eventually blindness, a severe sensory ataxia, achalasia, scoliosis, and inanition develop by third decade. Inversion recovery MRIs of the spinal cord in affected individuals demonstrate a hyperintense signal in the posterior columns. Finding the gene responsible for this disorder may aid in our understanding of the mechanisms that cause sensory neuronal degeneration.
Collapse
Affiliation(s)
- J J Higgins
- Clinical Neurogenetics Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
| | | | | | | |
Collapse
|
59
|
Hoon AH, Reinhardt EM, Kelley RI, Breiter SN, Morton DH, Naidu SB, Johnston MV. Brain magnetic resonance imaging in suspected extrapyramidal cerebral palsy: observations in distinguishing genetic-metabolic from acquired causes. J Pediatr 1997; 131:240-5. [PMID: 9290610 DOI: 10.1016/s0022-3476(97)70160-4] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Experienced clinicians recognize that some children who appear to have static cerebral palsy (CP) actually have underlying genetic-metabolic disorders. We report a series of patients with motor disorders seen in children with extrapyramidal CP in whom brain magnetic resonance imaging abnormalities provided important diagnostic clues in distinguishing genetic-metabolic disorders from other causes. One cause of static extrapyramidal CP, hypoxic-ischemic encephalopathy at the end of a term gestation, produces a characteristic pattern of hyperintense signal and atrophy in the putamen and thalamus. Other signal abnormalities and atrophy in the putamen, globus pallidus, or caudate can point to genetic-metabolic diseases, including disorders of mitochondrial and organic acid metabolism. Progress in understanding and treating genetic diseases of the developing brain makes it essential to diagnose disorders that masquerade as static CP. Brain magnetic resonance imaging is a useful diagnostic tool in the initial evaluation of children who appear to have CP.
Collapse
Affiliation(s)
- A H Hoon
- Department of Developmental Pediatrics, Kennedy Krieger Institute, Baltimore, MD 21205, USA
| | | | | | | | | | | | | |
Collapse
|
60
|
Biery BJ, Stein DE, Morton DH, Goodman SI. Gene structure and mutations of glutaryl-coenzyme A dehydrogenase: impaired association of enzyme subunits that is due to an A421V substitution causes glutaric acidemia type I in the Amish. Am J Hum Genet 1996; 59:1006-11. [PMID: 8900227 PMCID: PMC1914837] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
The structure of the human glutaryl coenzyme A dehydrogenase (GCD) gene was determined to contain 11 exons and to span approximately 7 kb. Fibroblast DNA from 64 unrelated glutaric acidemia type I (GA1) patients was screened for mutations by PCR amplification and analysis of SSCP. Fragments with altered electrophoretic mobility were subcloned and sequenced to detect mutations that caused GA1. This report describes the structure of the GCD gene, as well as point mutations and polymorphisms found in 7 of its 11 exons. Several mutations were found in more than one patient, but no one prevalent mutation was detected in the general population. As expected from pedigree analysis, a single mutant allele causes GA1 in the Old Order Amish of Lancaster County, Pennsylvania. Several mutations have been expressed in Escherichia coli, and all produce diminished enzyme activity. Reduced activity in GCD encoded by the A421V mutation in the Amish may be due to impaired association of enzyme subunits.
Collapse
Affiliation(s)
- B J Biery
- Department of Cellular and Structural Biology, University of Colorado School of Medicine, Denver 80262, USA
| | | | | | | |
Collapse
|
61
|
Morton DH. Through my window--remarks at the 125th year celebration of Children's Hospital of Boston. Pediatrics 1994; 94:785-91. [PMID: 7970991] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Affiliation(s)
- D H Morton
- Clinic for Special Children, Strasburg, Pennsylvania 17579
| |
Collapse
|
62
|
Mitsuuchi Y, Kawamoto T, Miyahara K, Ulick S, Morton DH, Naiki Y, Kuribayashi I, Toda K, Hara T, Orii T. Congenitally defective aldosterone biosynthesis in humans: inactivation of the P-450C18 gene (CYP11B2) due to nucleotide deletion in CMO I deficient patients. Biochem Biophys Res Commun 1993; 190:864-9. [PMID: 8439335 DOI: 10.1006/bbrc.1993.1128] [Citation(s) in RCA: 65] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
CYP11B2, the gene coding for steroid 18-hydroxylase (P-450C18), has been recently shown to be the same gene as that for corticosterone methyl oxidase type I and type II (CMO I & II) which were previously postulated to catalyze the final two steps in the biosynthesis of aldosterone in humans. Molecular genetic analysis of CYP11B2 of three patients affected with CMO I deficiency has revealed that deletion of 5 nucleotides occurs exclusively in exon 1, resulting in a frameshift to form a stop codon in the same exon. Thus, P-450C18 is not produced at all due to the mutation, causing a complete lack of aldosterone biosynthesis in the patients. Restriction fragment length polymorphism analysis has demonstrated that the patients are homozygous and the unaffected parent is heterozygous as for the mutation, indicating that CMO I deficiency is inherited in an autosomal recessive manner. These results provide the molecular genetic basis for the characteristic biochemical phenotype of CMO I deficient patients.
Collapse
Affiliation(s)
- Y Mitsuuchi
- Department of Medical Chemistry, Kochi Medical School, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
63
|
Abstract
Two inborn errors in the methyl oxidation of corticosterone to form aldosterone correspond to the two oxygenation-hydroxylation reactions required for this transformation. Both defects are characterized by overproduction of corticosterone of glomerulosa zone origin and deficient synthesis of aldosterone. In the type 1 corticosterone methyl oxidase defect (CMO I) impairment in the first step is reflected in decreased production of 18-hydroxycorticosterone while in CMO II an impaired second step is characterized by overproduction of 18-hydroxycorticosterone leading to an increased 18-hydroxycorticosterone:aldosterone metabolite ratio as a diagnostic index. This metabolite ratio may be increased somewhat in CMO I but not as much as in CMO II. The absolute value of 18-hydroxycorticosterone is a more reliable discriminator as is the corticosterone:18-hydroxycorticosterone metabolite ratio which is increased in CMO I and decreased in CMO II. On the basis of these findings, a North American kindred is reclassified as CMO I making this defect the more prevalent form in the Western Hemisphere. The two biochemical phenotypes will very likely describe different mutations in the gene encoding cytochrome P-450 CMO.
Collapse
Affiliation(s)
- S Ulick
- Veterans Affairs Hospital, Bronx, New York 10468
| | | | | |
Collapse
|
64
|
Morton DH, Bennett MJ, Seargeant LE, Nichter CA, Kelley RI. Glutaric aciduria type I: a common cause of episodic encephalopathy and spastic paralysis in the Amish of Lancaster County, Pennsylvania. Am J Med Genet 1991; 41:89-95. [PMID: 1951469 DOI: 10.1002/ajmg.1320410122] [Citation(s) in RCA: 105] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
We have diagnosed type I glutaric aciduria (GA-I) in 14 children from 7 Old Order Amish families in Lancaster County, Pennsylvania. An otherwise rare disorder, GA-I appears to be a common cause of acute encephalopathy and cerebral palsy among the Amish. The natural history of the disease, which was previously unrecognized in this population, is remarkably variable and ranges from acute infantile encephalopathy and sudden death to static extrapyramidal cerebral palsy to normal adult. Ten patients first manifested the disease between 3 and 18 months at the time of an acute infectious illness. Four of these children died in early childhood, also during acute illnesses. However, there has been little progression of the neurological disease after age 5 years in the surviving children and intellect usually has been preserved, even in children with severe spastic paralysis. When well, patients have plasma glutaric acid concentrations ranging from 4.8 to 14.2 mumol/liter (nl 0-5.6 mumol/liter) and urinary glutaric acid concentrations from 12.5 to 196 mg/g creatinine (nl 0.5-8.4 mg/g creatinine). We have found that GA-I can be diagnosed in the Amish by measurement of urinary glutaric acid concentrations using isotope-dilution gas chromatography/mass spectrometry, whereas the diagnosis can easily be missed by routine urine organic acid gas chromatography.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- D H Morton
- Clinic for Special Children, Strasburg, Pennsylvania 17579
| | | | | | | | | |
Collapse
|
65
|
Kuter BJ, Weibel RE, Guess HA, Matthews H, Morton DH, Neff BJ, Provost PJ, Watson BA, Starr SE, Plotkin SA. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 1991; 9:643-7. [PMID: 1659052 DOI: 10.1016/0264-410x(91)90189-d] [Citation(s) in RCA: 161] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
A large double-blind, randomized, placebo-controlled trial of live attenuated Oka/Merck varicella vaccine was conducted among healthy children, 1-14 years of age. During the first varicella season, the efficacy of the vaccine among susceptible children was 100%1. During the second varicella season, 22 children were diagnosed with varicella; 21 cases in placebo recipients and one in a vaccine recipient. The overall efficacy of the vaccine through two varicella seasons was 98%. After the code for the study was broken, the original group of vaccine recipients continued to be followed for development of varicella. The estimated proportion of vaccine recipients who remained varicella-free at the end of 7 years was 95%. The 23 cases of varicella that occurred in vaccine recipients over the 7-year period were considerably milder than natural varicella. The average number of lesions was 53, 50% of the children had non-vesicular rashes, and 14% of the children had a temperature greater than or equal to 38.9 degrees C (102 degrees F), oral. The persistence of antibody in a subset of vaccine recipients followed for 6 years was 100%.
Collapse
Affiliation(s)
- B J Kuter
- Department of Clinical Research, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486
| | | | | | | | | | | | | | | | | | | |
Collapse
|
66
|
Provost PJ, Krah DL, Kuter BJ, Morton DH, Schofield TL, Wasmuth EH, White CJ, Miller WJ, Ellis RW. Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine 1991; 9:111-6. [PMID: 1647574 DOI: 10.1016/0264-410x(91)90266-9] [Citation(s) in RCA: 92] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
An enzyme-linked immunosorbent assay for antibodies to varicella-zoster virus (VZV), using purified viral glycoproteins as antigen (gpELISA), was compared with other assays for measuring vaccine-induced antibody responses. The gpELISA was more sensitive than conventional assays, proved highly specific for VZV and agreed well with an assay for neutralizing antibody activity. It was successfully applied to large-scale testing of live varicella vaccine in humans.
Collapse
Affiliation(s)
- P J Provost
- Cellular and Molecular Biology, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486
| | | | | | | | | | | | | | | | | |
Collapse
|
67
|
Morton DH, Kelley RI. Diagnosis of medium-chain acyl-coenzyme A dehydrogenase deficiency in the neonatal period by measurement of medium-chain fatty acids in plasma and filter paper blood samples. J Pediatr 1990; 117:439-42. [PMID: 2391601 DOI: 10.1016/s0022-3476(05)81091-1] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- D H Morton
- Clinic for Special Children, Willow Lakes, Pennsylvania 17584
| | | |
Collapse
|
68
|
Abstract
A four-month-old child with non-ketotic hypoglycemia and rapidly progressive cirrhosis excreted in her urine large amounts of two unidentified organic acids in addition to a spectrum of saturated, unsaturated, and 3-hydroxy dicarboxylic acids in her urine. Gas chromatography/mass spectrometry of the trimethylsilyl derivative of one of the unknown compounds suggested the structure of 3-hydroxyoctanoic acid, which was confirmed by similar analysis of the authentic compound. The same organic acid was found in the child's plasma. The significance of 3-hydroxyoctanoic aciduria as a possible marker for a primary defect of 3-hydroxy fatty acid metabolism is discussed.
Collapse
Affiliation(s)
- R I Kelley
- Department of Genetics, Children's Hospital of Philadelphia, PA
| | | |
Collapse
|
69
|
Provost PJ, Keller PM, Banker FS, Keech BJ, Klein HJ, Lowe RS, Morton DH, Phelps AH, McAleer WJ, Ellis RW. Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virus. J Virol 1987; 61:2951-5. [PMID: 3041014 PMCID: PMC255866 DOI: 10.1128/jvi.61.10.2951-2955.1987] [Citation(s) in RCA: 25] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Abstract
The common marmoset, Callithrix jacchus, can be infected with human varicella-zoster virus (VZV), both wild-type strain KMcC and attenuated vaccine strain Oka/Merck. Infection was accomplished with either whole-cell-associated or cell extract VZV by combined oral-nasal-conjunctival application and was characterized by substantial and persistent anti-VZV antibody responses. The infectivity of VZV for marmosets was destroyed by treatment of inocula with heat or UV light. Diluted inocula with as few as 40 PFU/ml were infectious for marmosets. The lungs were demonstrated to be a major site of viral replication; both the presence of viral antigens and signs of pneumonia were demonstrated in lung tissues. Four serial passages of VZV KMcC were carried out in C. jacchus by a process of in vitro isolation and culturing of VZV from infected lung tissue and reapplication of the cultured isolates to fresh animals. The isolated viruses were identified as VZV both serologically and by restriction endonuclease analyses. The C. jacchus infectivity model should prove useful for determining the efficacy of subunit and live recombinant VZV vaccines as well as for the study of zoster.
Collapse
|
70
|
Zweerink HJ, Morton DH, Stanton LW, Neff BJ. Restriction endonuclease analysis of the DNA from varicella-zoster virus: stability of the DNA after passage in vitro. J Gen Virol 1981; 55:207-11. [PMID: 6271904 DOI: 10.1099/0022-1317-55-1-207] [Citation(s) in RCA: 27] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Abstract
DNA was extracted from nucleocapsids isolated from WI-38 cells infected with two different strains of varicella-zoster virus (VZV). The DNAs were treated with each of six restriction endonucleases (EcoRI, HindIII, Bg/I, Bg/II, Sal I and Bam-HI) and small, but reproducible differences in restriction endonuclease patterns were observed. These strains were passaged in WI-38 cells and in primary guinea-pig embryo (GPE) cells, followed by restriction endonuclease analysis of the DNAs. No changes were observed in the restriction prpofile of the DNA of one of the strains (VZV-KMcC) after 46 passages in WI-38 cells but small differences were observed after 72 passages. No changes were observed after 30 passages of another strain (VZV-AW) in WI-38 cells. Twenty passages of VZB-KMcC in GPE cells did result in minor alterations of its DNA. It was concluded that VZV DNA was sufficiently stable after multiple passages in WI-38 cells to make restriction endonuclease analysis a valuable epidemiological tool for strain differentiation.
Collapse
|
71
|
Neff BJ, Weibel RE, Villarejos VM, Buynak EB, McLean AA, Morton DH, Wolanski BS, Hilleman MR. Clinical and laboratory studies of KMcC strain live attenuated varicella virus. Proc Soc Exp Biol Med 1981; 166:339-47. [PMID: 6259644 DOI: 10.3181/00379727-166-41071] [Citation(s) in RCA: 37] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
|
72
|
Buynak EB, Whitman JE, Roehm RR, Morton DH, Lampson GP, Hilleman MR. Comparison of neutralization and hemagglutination-inhibition techniques for measuring mumps antibody. Proc Soc Exp Biol Med 1967; 125:1068-71. [PMID: 6042404 DOI: 10.3181/00379727-125-32278] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|